Chagas disease (American trypanosomiasis) in Mexico: an update.

Chagas disease is a parasitic infection caused by the protozoan Trypanosoma cruzi, a flagellated organism that is transmitted mainly to humans through the infected feces of triatomine kissing bugs (vector transmission in endemic areas) or by transfusion of infected blood, donations of infected organ, or transmission from an infected mother to her child at birth. Chagas disease was first described in 1909 by the Brazilian physician Carlos Chagas, and due to the parasite's distribution throughout North, Central and South America, the disease is commonly known as American trypanosomiasis. However, this disease is now present in non-endemic countries such as Canada, the United States of America, and several countries in Europe (principally Spain). Moreover, Chagas disease was recently designated by the World Health Organization as one of the main neglected tropical diseases. The aim of this review is to summarize the research efforts recently described in studies conducted in Mexico on Chagas disease. In this country, there are no existing vector control programs. In addition, there is no consensus on the diagnostic methods for acute and chronic Chagas disease in maternity wards and blood banks, and trypanocidal therapy is not administered to chronic patients. The actual prevalence of the disease is unknown because no official reporting of cases is performed. Therefore, the number of people infected by different routes of transmission (vector, congenital, blood transfusion, organ transplantation, or oral) is unknown. We believe that by promoting education about Chagas disease in schools starting at the basic elementary level and including reinforcement at higher education levels will ensure that the Mexican population would be aware of this health problem and that the control measures adopted will have more acceptance and success. We hope that this review sensitizes the relevant authorities and that the appropriate measures to reduce the risk of infection by T. cruzi are undertaken to provide the Mexican people a better quality of life.

[1]  J. L. Rosales-Encína,et al.  Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model , 2012, Veterinary Research.

[2]  Y. Carlier,et al.  Maternal fetal transmission of Trypanosoma cruzi: a problem of public health little studied in Mexico. , 2012, Experimental parasitology.

[3]  R. Chuit,et al.  Evaluation of dogs as sentinels of the transmission of Trypanosoma cruzi in a rural area of north-western Argentina. , 1998, Annals of tropical medicine and parasitology.

[4]  C. Guzmán-Bracho,et al.  American trypanosomiasis (Chagas' disease) and blood banking in Mexico City: seroprevalence and its potential transfusional transmission risk. , 1999, Archives of medical research.

[5]  M. E. Berne,et al.  Anti-Trypanosoma cruzi antibody detection in blood donors in the Southern Brazil. , 2008, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[6]  C. Ericsson,et al.  NEW FOCUS OF CHAGAS' DISEASE IN MEXICO , 1987, The Lancet.

[7]  F. Zicker,et al.  Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. , 2001, The American journal of tropical medicine and hygiene.

[8]  Alejandro Cruz-Reyes,et al.  Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years--a review. , 2006, Memorias do Instituto Oswaldo Cruz.

[9]  C V Vassena,et al.  Insecticide resistance in Brazilian Triatoma infestans and Venezuelan Rhodnius prolixus , 2000, Medical and veterinary entomology.

[10]  Á. Moncayo Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. , 2003, Memorias do Instituto Oswaldo Cruz.

[11]  R. Gazzinelli,et al.  The role of parasite persistence in pathogenesis of Chagas heart disease , 2009, Parasite immunology.

[12]  J. Guégan,et al.  High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. , 2002, Memorias do Instituto Oswaldo Cruz.

[13]  Y. Carlier,et al.  Congenital infection by Trypanosoma cruzi in an endemic area of Chile: a multidisciplinary study. , 2013, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  E. Zerba Susceptibility and resistance to insecticides of Chagas disease vectors. , 1999, Medicina.

[15]  G. Gutiérrez,et al.  Seroepidemiología de la enfermedad de Chagas en México , 1992 .

[16]  Anna Petherick,et al.  Country by country , 2010, Nature.

[17]  J. Muñoz,et al.  Congenital transmission of Chagas disease: a clinical approach , 2010, Expert review of anti-infective therapy.

[18]  R. Gürtler,et al.  Chagas disease in north-west Argentina: association between Trypanosoma cruzi parasitaemia in dogs and cats and infection rates in domestic Triatoma infestans. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  J. R. Gonzalez-Galaviz,et al.  Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico. , 2009, The American journal of tropical medicine and hygiene.

[20]  S. Trevethan,et al.  Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. , 2005, Memorias do Instituto Oswaldo Cruz.

[21]  Marco A. Becerril-Flores,et al.  Descripción de la enfermedad de Chagas en el Valle de Iguala Guerrero, México , 2003 .

[22]  C. Guzmán-Bracho,et al.  Human Trypanosoma cruzi Infection and Seropositivity in Dogs, Mexico , 2006, Emerging infectious diseases.

[23]  E. Segura,et al.  Congenital Transmission of Trypanosoma cruzi Infection in Argentina , 2003, Emerging infectious diseases.

[24]  R. Corrêa-Oliveira,et al.  Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. , 2007, Human pathology.

[25]  B. Nogueda-Torres,et al.  Distribution and infection of triatomines (Hemiptera: Reduviidae) by Trypanosoma cruzi in the state of Michoacán, Mexico. , 2011, Memorias do Instituto Oswaldo Cruz.

[26]  R. Dantas,et al.  Gastrointestinal manifestations of chagas’ disease , 1998 .

[27]  Z. Andrade,et al.  Immunopathology of Chagas disease. , 1999, Memorias do Instituto Oswaldo Cruz.

[28]  J. Coura,et al.  Chagas disease: a new worldwide challenge , 2010, Nature.

[29]  S. Weisenberg,et al.  Seroprevalence of Chagas Infection in the Donor Population , 2012, PLoS neglected tropical diseases.

[30]  J. Gascón,et al.  Chagas disease and stroke , 2010, The Lancet Neurology.

[31]  E. C. Oliveira,et al.  Neurochemical Coding of the Enteric Nervous System in Chagasic Patients with Megacolon , 2007, Digestive Diseases and Sciences.

[32]  M. Miles Control of Chagas disease. Report of a WHO Expert Committee. , 1993, World Health Organization technical report series.

[33]  J. Laclette,et al.  Entomological indices, feeding sources, and molecular identification of Triatoma phyllosoma (Hemiptera: Reduviidae) one of the main vectors of Chagas disease in the Istmo de Tehuantepec, Oaxaca, Mexico. , 2011, The American journal of tropical medicine and hygiene.

[34]  J. Chippaux,et al.  Prevalence of Chagas disease in pregnant women and incidence of congenital transmission in Santa Cruz de la Sierra, Bolivia. , 2012, Acta tropica.

[35]  Víctor M Monteón-Padilla,et al.  Cardiopatía chagásica crónica en el Hospital General de Zona N° 24 IMSS. Poza Rica, Veracruz , 2006 .

[36]  C. Bern Antitrypanosomal therapy for chronic Chagas' disease. , 2011, The New England journal of medicine.

[37]  C. Bern,et al.  Chagas disease in Spain, the United States and other non-endemic countries. , 2010, Acta tropica.

[38]  M. Vallejo-Allende,et al.  [Specific dilated myocardiopathy. Chronic chagasic cardiopathy at the National Institute of Cardiology Ignacio Chávez]. , 2002, Archivos de cardiologia de Mexico.

[39]  T. Okay,et al.  Reactivation of Trypanosoma cruzi infection in immunosuppressed patients: contributions for the laboratorial diagnosis standardization. , 2008, Revista do Instituto de Medicina Tropical de Sao Paulo.

[40]  P. Hotez,et al.  Control of neglected tropical diseases. , 2007, The New England journal of medicine.

[41]  R. Dantas,et al.  Gallbladder motor function in chagasic patients with megacolon and/or megaesophagus. , 1987, Digestion.

[42]  Z. Cucunubá,et al.  Prevalence and risk factors for Chagas disease in pregnant women in Casanare, Colombia. , 2012, The American journal of tropical medicine and hygiene.

[43]  O. Coll,et al.  Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  E. Chiari,et al.  Experimental Chagas' disease in dogs. , 1992, Memorias do Instituto Oswaldo Cruz.

[45]  Olivia Rodríguez-Morales,et al.  Trypanosoma cruzi connatal transmission in dogs with Chagas disease: experimental case report. , 2011, Vector borne and zoonotic diseases.

[46]  C. Carneiro,et al.  Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs. , 2007, Memorias do Instituto Oswaldo Cruz.

[47]  J. T. Zavala,et al.  Enfermedad de Chagas en el estado de Puebla. Reporte de nuevas localidades infectadas , 2006 .

[48]  J. L. Rosales-Encína,et al.  Specific humoral and cellular immunity induced by Trypanosoma cruzi DNA immunization in a canine model , 2013, Veterinary Research.

[49]  S. Sauleda,et al.  Seroprevalence of Trypanosoma cruzi infection in at‐risk blood donors in Catalonia (Spain) , 2008, Transfusion.

[50]  J. Ramsey,et al.  Efficacy of Pyrethroid Insecticides Against Domestic and Peridomestic Populations of Triatoma pallidipennis and Triatoma barberi (Reduviidae:Triatominae) Vectors of Chagas’ Disease in Mexico , 2003, Journal of medical entomology.

[51]  A Prata,et al.  Clinical and epidemiological aspects of Chagas disease. , 2001, The Lancet. Infectious diseases.

[52]  A. Silveira Os novos desafios e perspectivas futuras do controle , 2011 .

[53]  Pazmiño Salazar,et al.  Seroprevalencia de anticuerpos contra Trypanosoma cruzi y su asociación con factores de riesgo en menores de 18 años de Veracruz, México , 2007 .

[54]  E. Read,et al.  Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission , 2002, Transfusion.

[55]  K. Snowden,et al.  Distribution and characterization of canine Chagas disease in Texas. , 2008, Veterinary parasitology.

[56]  I. Arteaga,et al.  Chagas disease in Mexico , 1988 .

[57]  E. Dumonteil,et al.  Update on Chagas' disease in Mexico. , 1999, Salud publica de Mexico.

[58]  Peter J Hotez,et al.  Rescuing the bottom billion through control of neglected tropical diseases , 2009, The Lancet.

[59]  L. Aprile,et al.  Abnormally Rapid Gastric Emptying of an Isosmotic Liquid Meal in Patients with Megaduodenum , 2000, Digestive Diseases and Sciences.

[60]  C. Bilder,et al.  The Enteric Nervous System in Chagasic and Idiopathic Megacolon , 2007, The American journal of surgical pathology.

[61]  L. Capps,et al.  Chagas cardiomyopathy and serologic testing in a small rural hospital in Chiapas, Mexico. , 2004, Revista panamericana de salud publica = Pan American journal of public health.

[62]  K. Acosta-Viana,et al.  American trypanosomiasis in dogs from an urban and rural area of Yucatan, Mexico. , 2008, Vector borne and zoonotic diseases.

[63]  B. Vasavada,et al.  Clinical aspects of the Chagas' heart disease. , 2007, International journal of cardiology.

[64]  P. M. Salazar-schettino,et al.  DETECTION OF ANTIBODIES AGAINST Trypanosoma cruzi IN BLOOD DONORS IN THE GENERAL HOSPITAL OF MEXICO CITY , 2008 .

[65]  R. Chuit,et al.  Incidence of trypanosoma cruzi infection among children following domestic reinfestation after insecticide spraying in rural northwestern Argentina. , 2005, The American journal of tropical medicine and hygiene.

[66]  J. Defreitas,et al.  [Epidemiology of Chagas' disease]. , 1961, Hospital.

[67]  Bruce Y. Lee,et al.  Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects , 2012, Expert review of vaccines.

[68]  U. Meneghelli Chagasic enteropathy. , 2004, Revista da Sociedade Brasileira de Medicina Tropical.

[69]  P. Reyes,et al.  Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma Cruzi en el municipio de Palmar de Bravo, Puebla, México , 2004 .

[70]  E. Murphy,et al.  Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina , 2009, Transfusion.

[71]  S. Montgomery,et al.  The United States Trypanosoma cruzi Infection Study: evidence for vector‐borne transmission of the parasite that causes Chagas disease among United States blood donors , 2012, Transfusion.

[72]  E. Dumonteil,et al.  Identification of a hyperendemic area for Trypanosoma cruzi infection in central Veracruz, Mexico. , 2010, The American journal of tropical medicine and hygiene.

[73]  J. Dias [Epidemiological surveillance of Chagas disease]. , 2000, Cadernos de saude publica.

[74]  P. Deloron,et al.  Congenital parasitic infections: a review. , 2012, Acta tropica.

[75]  M. J. Muñoz-Dávila,et al.  Risk factors and primary prevention of congenital Chagas disease in a nonendemic country. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  E. Dumonteil,et al.  Therapeutic DNA Vaccine against Trypanosoma cruzi Infection in Dogs , 2008, Annals of the New York Academy of Sciences.

[77]  V. Sánchez‐Cordero,et al.  Ecology of North American Triatominae. , 2009, Acta tropica.

[78]  S. Montgomery,et al.  An estimate of the burden of Chagas disease in the United States. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  A. Peterson,et al.  Ecologic Niche Modeling and Potential Reservoirs for Chagas Disease, Mexico. , 2002, Emerging infectious diseases.

[80]  J. Dias,et al.  The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery. , 1999, Memorias do Instituto Oswaldo Cruz.

[81]  P. Hotez,et al.  Bridging the innovation gap for neglected tropical diseases in México: capacity building for the development of a new generation of antipoverty vaccines , 2011 .

[82]  M. Rossi,et al.  Postmortem studies of the intertruncal plexus and cardiac conduction system from patients with Chagas disease who died suddenly. , 2005, Progress in cardiovascular diseases.

[83]  J. C. Vazquez-Chagoyán,et al.  Vaccine development against Trypanosoma cruzi and Chagas disease. , 2011, Advances in parasitology.

[84]  M. Sánchez-Moreno,et al.  Seroprevalence of Antibodies Against the Excreted Antigen Superoxide Dismutase by Trypanosoma Cruzi in Dogs From the Yucatan Peninsula (Mexico) , 2013, Zoonoses and public health.

[85]  J. Dujardin,et al.  Phylogeography and Genetic Variation of Triatoma dimidiata, the Main Chagas Disease Vector in Central America, and Its Position within the Genus Triatoma , 2008, PLoS neglected tropical diseases.

[86]  J. L. Imbert-Palafox,et al.  Human infection and risk of transmission of Chagas disease in Hidalgo State, Mexico. , 2007, The American journal of tropical medicine and hygiene.

[87]  B. Herwaldt,et al.  Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. , 2008, The Journal of infectious diseases.

[88]  Y. Yamagata,et al.  Control of Chagas disease. , 2006, Advances in parasitology.

[89]  M. T. Cosme,et al.  Riesgo de transmisión de Trypanosoma cruzi por transfusión de sangre en México , 1998 .

[90]  N. M. Matsuda,et al.  The Chronic Gastrointestinal Manifestations of Chagas Disease , 2009, Clinics.

[91]  U. Kitron,et al.  A prospective study of the effects of sustained vector surveillance following community-wide insecticide application on Trypanosoma cruzi infection of dogs and cats in rural Northwestern Argentina. , 2006, The American journal of tropical medicine and hygiene.

[92]  F. Espinoza-Gomez,et al.  Active transmission of human chagas disease in Colima Mexico. , 2004, Memorias do Instituto Oswaldo Cruz.

[93]  A. Barbabosa‐Pliego,et al.  Testing the Efficacy of a Multi-Component DNA-Prime/DNA-Boost Vaccine against Trypanosoma cruzi Infection in Dogs , 2011, PLoS neglected tropical diseases.

[94]  M. Culpin Psychoanalysis and Suicide , 1926 .

[95]  M. Reis,et al.  Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain. , 2003, Revista da Sociedade Brasileira de Medicina Tropical.

[96]  Celso Ramos,et al.  Anticuerpos contra Trypanosoma cruzi en humanos y perros y presencia del parásito en Meccus pallidipennis en la localidad de Puente Pantitlán, Morelos, México , 2011 .

[97]  K. Acosta-Viana,et al.  Serological survey of American trypanosomiasis in dogs and their owners from an urban area of Mérida Yucatàn, México. , 2010, Transboundary and emerging diseases.

[98]  J. Altcheh,et al.  Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. , 2003, The Journal of antimicrobial chemotherapy.

[99]  C. Guzmán-Bracho,et al.  Epidemiology of Chagas disease in Mexico: an update. , 2001, Trends in parasitology.

[100]  A. Peterson,et al.  Fine-scale predictions of distributions of Chagas disease vectors in the state of Guanajuato, Mexico. , 2005, Journal of medical entomology.

[101]  U. Kitron,et al.  Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina , 2006, Parasitology.

[102]  J. C. Vazquez-Chagoyán,et al.  Risk factors associated with triatomines and its infection with Trypanosoma cruzi in rural communities from the southern region of the State of Mexico, Mexico. , 2010, The American journal of tropical medicine and hygiene.

[103]  Rodolfo Viotti,et al.  Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment , 2006, Annals of Internal Medicine.

[104]  Robert H Gilman,et al.  Evaluation and treatment of chagas disease in the United States: a systematic review. , 2007, JAMA.

[105]  A. Silveira,et al.  O controle da transmissão vetorial , 2011 .

[106]  Víctor M Monteón,et al.  Distribución heterogénea de la prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre en Puebla, México , 2005 .

[107]  C. Guzmán-Bracho,et al.  Trypanosoma cruzi circulating in the southern region of the State of Mexico (Zumpahuacan) are pathogenic: a dog model. , 2009, The American journal of tropical medicine and hygiene.